NPS Pharmaceuticals Inc's hormone replacement therapy Natpara appears effective, though data from one clinical trial site was excluded due to manufacturing violations, according to a preliminary report...
The FDA has approved pembrolizumab (Keytruda) for the treatment of advanced or unresectable melanoma in patients that are no longer responding to other drugs.
Melatonin does not reduce the incidence of delirium among patients aged 65 and older who are hospitalized with hip fracture, researchers from the Netherlands report.
Primary care practitioners should be aware of 3 new FDA approvals that may be useful when treating patients with cervical cancer, multiple sclerosis, and insomnia.
Children who receive growth hormone to treat short stature or hormone deficiency may be at an increased risk of ischemic stroke as young adults, suggests a new European study.
